Biocon executive chairperson Kiran Mazumdar-Shaw said AI could reduce the time taken to develop a drug molecule from five to seven years to one or two years, while transforming clinical trials, diagnostics and biological research. New Delhi, Nov 17 (PTI) Artificial Intelligence (AI) has the potential to drastically cut the time required to take a drug molecule from the lab to patients, compressing the current.